ERBB2 and triple-negative breast carcinoma: As a particularly aggressive subtype, triple negative breast cancer (TNBC) has been regarded as the most challenging breast cancer without hormone receptors and human epidermal growth factor receptor 2 (HER2) gene amplification, which commonly results in greater metastatic potential, higher rates of relapse, together with shorter overall survival compared with other subtypes (3).